Certara, Inc. (CERT)
NASDAQ · Services · Services-prepackaged software
$9.11+$0.2200 (+2.47%) on the dayAs of the close; data may be delayed.
CERT price, last 12 months
Key stats
- Previous close
- $8.89
- Open
- $8.96
- Day range
- $8.74 – $9.21
- 52-week range
- $4.45 – $13.88
- Volume
- 2.9M
- Avg volume (20 days)
- 2.4M
- Market cap
- $1.4B
Performance
1W+8.2%
1M+10.8%
3M+56.0%
6M+48.4%
YTD+3.4%
1Y−20.5%
vs S&P 500, 1Y−37.3 pts
Technicals and fundamentals
About Certara, Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
- Sector
- Services
- Industry
- Services-prepackaged software
- Listed on
- NASDAQ
- Market cap
- $1.4B